TIGIT and neoplasm: TIGIT has many ligands, CD155 (PVR or Necl-5), CD112 (nectin-2, also known as PRR2 or PVRL2), and CD113, CD155, CD112, CD113, and CD111, which are expressed in APCs or tumor cells.